Hypertension Case Study Analysis
\nAbstract:
\nThis paper presents an analysis of a hypertension case study involving a 40-year-old African American male patient. The patient’s medical history, family history, social history, medications, review of systems, physical exam findings, and lab results are examined to identify key risk factors, diagnose the severity of hypertension, and determine an appropriate treatment plan. Relevant pathophysiology of hypertension is also discussed. The case study provides insights into the multifactorial nature of hypertension and underscores the importance of a thorough patient evaluation to guide evidence-based management.
\nIntroduction:
\nHypertension, defined as persistently elevated blood pressure, is a major risk factor for cardiovascular disease and a leading cause of morbidity and mortality worldwide (Unger et al., 2020). Effective diagnosis and management of hypertension requires consideration of a patient’s unique combination of risk factors, comorbidities, and lifestyle habits. The following case study of a 40-year-old male with uncontrolled hypertension illustrates key principles in the clinical approach to this common condition.
\nPatient Presentation:
\nE.W., a 40-year-old African American male, presented to his primary care provider for a physical exam and to renew his antihypertensive medication prescription. He had an 11-year history of hypertension that had become more difficult to control. The patient’s medical history was significant for chronic sinus infections, pneumonia, and an episode of depression after his wife’s suicide 5 years prior. Family history revealed premature paternal death from a myocardial infarction, as well as maternal diabetes and hypertension.
\nSocial history uncovered several behavioral risk factors, including occupational stress as an air traffic controller, past smoking, regular alcohol consumption, high dietary sodium intake, and lack of exercise. His current medications included hydrochlorothiazide, pseudoephedrine, and beclomethasone.
\nPhysical examination was notable for obesity (BMI 31), elevated blood pressure (155\/96 mmHg), an S3 heart sound, and basilar crackles on lung auscultation. Fundoscopy showed mild arteriolar narrowing. Lab results revealed left ventricular hypertrophy on ECG and echocardiography, as well as hypertriglyceridemia and low HDL.
\nDiscussion:
\nThis African American patient demonstrates numerous risk factors for hypertension, including obesity, high sodium intake, alcohol use, sedentary lifestyle, family history, and psychosocial stress (Chor et al., 2016). His uncontrolled blood pressure and target organ damage in the form of left ventricular hypertrophy and retinopathy indicate at least stage 2 hypertension (Carey & Whelton, 2018). The presence of lung crackles and a third heart sound may reflect pulmonary edema and volume overload from hypertensive heart disease.
\nThe patient’s hydrochlorothiazide dose of 50 mg daily exceeds the recommended starting dose of 12.5-25 mg for hypertension (Carter, 2022). Thiazide diuretics can cause hypokalemia, hyperglycemia, and hyperuricemia, necessitating monitoring of serum chemistries. The patient’s elevated GGT likely stems from regular alcohol use. Alcohol, pseudoephedrine (taken for sinus symptoms), and occupational stress may all be contributing to resistant hypertension in this case (Sim et al., 2019).
\nTreatment goals include lowering blood pressure to <130\/80 mmHg, regression of end-organ damage, and reduction of atherosclerotic cardiovascular disease risk through lifestyle changes and pharmacotherapy (Unger et al., 2020). Adding a renin-angiotensin system inhibitor and calcium channel blocker should be considered to improve blood pressure control. Lifestyle interventions should target weight loss, reduced sodium and alcohol intake, the DASH diet, and increased physical activity (Carey & Whelton, 2018).\nConclusion:\nThis case illustrates the complex interplay of genetic, environmental, and behavioral factors that contribute to the development and progression of hypertension. A detailed history and examination are essential to identify an individual's unique risk factors and to classify the severity of hypertension. Treatment must be personalized and combine judiciously selected antihypertensive medications with lifestyle modifications for optimal outcomes. Regular follow-up is necessary to monitor treatment response, adjust therapy as needed, and assess for adverse drug effects and end-organ damage.\nReferences:\nCarey, R. M., & Whelton, P. K. (2018). Prevention, detection, evaluation, and management of high blood pressure in adults: Synopsis of the 2017 American College of Cardiology\/American Heart Association hypertension guideline. Annals of Internal Medicine, 168(5), 351-358. https:\/\/doi.org\/10.7326\/M17-3203\nCarter, K. (2022). Starting doses for antihypertensive drugs. American Family Physician, 105(1), 112-113. https:\/\/www.aafp.org\/pubs\/afp\/issues\/2022\/0100\/starting-antihypertensive-doses.html\nChor, D., Pinho Ribeiro, A. L., S\u00e1 Carvalho, M., Duncan, B. B., Andrade Lotufo, P., Ara\u00fajo Nobre, A., Aquino, E. M., Schmidt, M. I., Griep, R. H., Molina, M., Barreto, S. M., Passos, V. M., Bense\u00f1or, I. J., Matos, S., & Mill, J. G. (2016). Prevalence, awareness, treatment and influence of socioeconomic variables on control of high blood pressure: Results of the ELSA-Brasil study. PLoS One, 10(6), e0127382. https:\/\/doi.org\/10.1371\/journal.pone.0127382\nSim, J. J., Bhandari, S. K., Shi, J., Reynolds, K., Calhoun, D. A., Kalantar-Zadeh, K., & Jacobsen, S. J. (2019). Comparative risk of renal, cardiovascular, and mortality outcomes in controlled, uncontrolled resistant, and nonresistant hypertension. Kidney International, 88(3), 622-632. https:\/\/doi.org\/10.1038\/ki.2015.142\nUnger, T., Borghi, C., Charchar, F., Khan, N. A., Poulter, N. R., Prabhakaran, D., Ramirez, A., Schlaich, M., Stergiou, G. S., Tomaszewski, M., Wainford, R. D., Williams, B., & Schutte, A. E. (2020). 2020 International Society of Hypertension global hypertension practice guidelines. Hypertension, 75(6), 1334-1357. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.120.15026\n\n+++++++++++++++++\nHypertension Case Study\nPATIENT CASE\nHPI\nE.W. is a 40-year-old African American male, who has had difficulty controlling his HTN lately.\nHe is visiting his primary care provider for a thorough physical examination and to renew a prescription to continue his blood pressure medication.\nPMH\n\u2022 Chronic sinus infections\n\u2022 Hypertension for approximately 11 years\n\u2022 Pneumonia 6 years ago that resolved with antibiotic therapy\n\u2022 One major episode of major depressive illness caused by the suicide of his wife of 15 years, 5 years ago\n\u2022 No surgeries\nFH\n\u2022 Father died at age 49 from AMI; had HTN\n\u2022 Mother has DM and HTN\n\u2022 Brother died at age 20 from complications of CF\n\u2022 Two younger sisters are A&W\nSH\nThe patient is a widower and lives alone. He has a 15-year-old son who lives with a maternal aunt. He has not spoken with his son for four years. The patient is an air traffic controller at the local airport. He smoked cigarettes for approximately 10 years but stopped\nsmoking when he was diagnosed with HTN. He drinks \u201cseveral beers every evening to relax\u201d\nCASE STUDY\n5 HYPERTENSION\nFor the Disease Summary for this case study,\nsee the CD-ROM.\n\nCASE STUDY 5 \u25a0 HYPERTENSION 19\nand does not pay particular attention to the sodium, fat, or carbohydrate content of the foods that he eats. He admits to \u201csalting almost everything he eats, sometimes even before tasting it.\u201d He denies ever having dieted. He takes an occasional walk but has no regular daily exercise program.\nPatient Case Question 1. Identify six risk factors for hypertension in this patient\u2019s\nhistory.\nMeds\n\u2022 Hydrochlorothiazide 50 mg po QD\n\u2022 Pseudoephedrine hydrochloride 60 mg po q6h PRN\n\u2022 Beclomethasone dipropionate 1 spray into each nostril q6h PRN\nPatient Case Question 2. Why is the patient taking hydrochlorothiazide and what is the primary pharmacologic mechanism of action of the drug?\nPatient Case Question 3. Why is the patient taking pseudoephedrine hydrochloride and what is the primary pharmacologic mechanism of action of the drug?\nPatient Case Question 4. Why is the patient taking beclomethasone dipropionate and what is the primary pharmacologic mechanism of action of the drug?\nAll\nRash with penicillin use\nROS\n\u2022 States that his overall health has been fair to good during the past 12 months\n\u2022 Weight has increased by approximately 20 pounds during the last year\n\u2022 Denies chest pain, shortness of breath at rest, headaches, nocturia, nosebleeds, and hemoptysis\n\u2022 Reports some shortness of breath with activity, especially when climbing stairs, and that breathing difficulties are getting worse\n\u2022 Denies any nausea, vomiting, diarrhea, or blood in the stool\n\u2022 Self-treats occasional right knee pain with OTC extra-strength acetaminophen\n\u2022 Denies any genitourinary symptoms\nPatient Case Question 5. What is the most clinically significant information related to\nHTN in this review of systems?\nPhysical Exam and Lab Tests\nGen\nThe patient is an obese black man in no apparent distress. He appears to be his stated age.\n\n20 PART 1 \u25a0 CARDIOVASCULAR DISORDERS\nPatient Case Table 5.1 Vital Signs\nAverage BP 155\/96 mm Hg (sitting) Ht 5\u000111\nHR 73 and regular Wt 221 lb\nRR 15 and unlabored BMI 31.0\nT 98.8\u00b0F\nVital Signs\nSee Patient Case Table 5.1\nPatient Case Question 6. Identify the two most clinically significant vital signs relative\nto this patient\u2019s HTN.\nHEENT\n\u2022 TMs intact and clear throughout\n\u2022 No nasal drainage\n\u2022 No exudates or erythema in oropharynx\n\u2022 PERRLA, pupil diameter 3.0 mm bilaterally\n\u2022 Sclera without icterus\n\u2022 EOMI\n\u2022 Funduscopy reveals mild arteriolar narrowing with no nicking, hemorrhages, exudates, or\npapilledema\nPatient Case Question 7. What is the significance of the HEENT examination?\nNeck\n\u2022 Supple without masses or bruits\n\u2022 Thyroid normal\n\u2022 () lymphadenopathy\nLungs\n\u2022 Mild basilar crackles bilaterally\n\u2022 No wheezes\nHeart\n\u2022 RRR\n\u2022 Prominent S3 sound\n\u2022 No murmurs or rubs\nPatient Case Question 8. Which abnormalities in the heart and lung examinations may be related and why might these clinical signs be related?\n\nCASE STUDY 5 \u25a0 HYPERTENSION 21\nAbd\n\u2022 Soft and ND\n\u2022 NT with no guarding or rebound\n\u2022 No masses, bruits, or organomegaly\n\u2022 Normal BS\nRectal\/GU\n\u2022 Normal size prostate without nodules or asymmetry\n\u2022 Heme () stool\n\u2022 Normal penis and testes\nExt\n\u2022 No CCE\n\u2022 Limited ROM right knee\nNeuro\n\u2022 No sensory or motor abnormalities\n\u2022 CNs II\u2013XII intact\n\u2022 Negative Babinski\n\u2022 DTRs \u0004 2\u0005\n\u2022 Muscle tone \u0004 5\/5 throughout\nPatient Case Question 9. Are there any abnormal neurologic findings and, if so, might\nthey be caused by HTN?\nLaboratory Blood Test Results\nSee Patient Case Table 5.2\nPatient Case Table 5.2 Laboratory Blood Test Results\nNa 139 meq\/L RBC 5.9 million\/mm3 Mg 2.4 mg\/dL\nK 3.9 meq\/L WBC 7,100\/mm3 PO4 3.9 mg\/dL\nCl 102 meq\/L AST 29 IU\/L Uric acid 7.3 mg\/dL\nHCO3 27 meq\/L ALT 43 IU\/L Glu, fasting 110 mg\/dL\nBUN 17 mg\/dL Alk phos 123 IU\/L T. cholesterol 275 mg\/dL\nCr 1.0 mg\/dL GGT 119 IU\/L HDL 31 mg\/dL\nHb 16.9 g\/dL T. bilirubin 0.9 mg\/dL LDL 179 mg\/dL\nHct 48% T. protein 6.0 g\/dL Trig 290 mg\/dL\nPlt 235,000\/mm3 Ca 9.3 mg\/dL PSA 1.3 ng\/mL\nPatient Case Question 10. Why might this patient\u2019s GGT be abnormal?\nPatient Case Question 11. Identify three other clinically significant lab tests above.\nB\n22 PART 1 \u25a0 CARDIOVASCULAR DISORDERS\nPatient Case Table 5.3 Urinalysis\nAppearance Clear and amber in color Microalbuminuria (\u0005)\nSG 1.017 RBC 0\/hpf\npH 5.3 WBC 0\/hpf\nProtein () Bacteria ()\nUrinalysis\nSee Patient Case Table 5.3\nPatient Case Question 12. What is the clinical significance of the single abnormal\nurinalysis finding?\nECG\nIncreased QRS voltage suggestive of LVH\nECHO\nModerate LVH with EF \u0004 46%\nPatient Case Question 13. What is the likely pathophysiologic mechanism for LVH\nin this patient?\nPatient Case Question 14. What does the patient\u2019s EF suggest?\n<\/p>\n","protected":false},"excerpt":{"rendered":"
Hypertension Case Study Analysis Abstract: This paper presents an analysis of a hypertension case study involving a 40-year-old African American male patient. The patient’s medical history, family history, social history, medications, review of systems, physical exam findings, and lab results are examined to identify key risk factors, diagnose the severity of hypertension, and determine an […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[20,591,1832,787,1391,907],"tags":[1838,1837],"class_list":["post-8452","post","type-post","status-publish","format-standard","hentry","category-ace-myhomework","category-case-study-assignment-homework-help","category-pathophysiology-case-study-examples","category-patient-case-study-assignment-help","category-pharmacology-case-study","category-write-answer-to-a-medical-case-study-assignment","tag-e-w-is-a-40-year-old-african-american-male","tag-hypertension-case-study"],"_links":{"self":[{"href":"https:\/\/www.colapapers.com\/essays\/wp-json\/wp\/v2\/posts\/8452","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.colapapers.com\/essays\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.colapapers.com\/essays\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.colapapers.com\/essays\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.colapapers.com\/essays\/wp-json\/wp\/v2\/comments?post=8452"}],"version-history":[{"count":1,"href":"https:\/\/www.colapapers.com\/essays\/wp-json\/wp\/v2\/posts\/8452\/revisions"}],"predecessor-version":[{"id":8453,"href":"https:\/\/www.colapapers.com\/essays\/wp-json\/wp\/v2\/posts\/8452\/revisions\/8453"}],"wp:attachment":[{"href":"https:\/\/www.colapapers.com\/essays\/wp-json\/wp\/v2\/media?parent=8452"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.colapapers.com\/essays\/wp-json\/wp\/v2\/categories?post=8452"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.colapapers.com\/essays\/wp-json\/wp\/v2\/tags?post=8452"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}